US Patent 11135226 Use of reboxetine to treat narcolepsy
Patent 11135226 was granted and assigned to Axsome Therapeutics on October, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11135226 Use of reboxetine to treat narcolepsy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
